Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


PI3 kinase inhibitor
BML-EI390-0010 10 mg 82.00 USD
BML-EI390-0050 50 mg 323.00 USD
Do you need bulk/larger quantities?
A selective PI 3-Kγ isoform inhibitor (IC50 = 0.24, 1.45, 0.07 and 1.70μM for α, β, γ and δ isoforms respectively). Blocks RANTES-induced neutrophil migration and displays anti-inflammatory activity in various in vivo rodent models.

Product Details

Alternative Name:NSC31098, 5-Benzo[1,3]dioxol-5-ylmethylene-thiazolidine-2,4-dione
Purity:≥98% (TLC)
Appearance:Yellow solid.
Solubility:Soluble in DMSO (25mg/mL). For in vivo administration this compound was suspended in 0.5% carboxymethylcellulose/0.25% Tween 20 as a vehicle.
Long Term Storage:Ambient
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment: C. Ferrandi, et al.; J. Pharmacol. Exp. Ther. 322, 923 (2007), Abstract;

Related Literature

Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

All new literature pieces